Teza Capital Management’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $261K | Sell |
6,604
-3,640
| -36% | -$144K | 0.19% | 207 |
|
|
2025
Q1 | $309K | Buy |
10,244
+1,719
| +20% | +$51.9K | 0.14% | 251 |
|
|
2024
Q4 | $298K | Sell |
8,525
-2,075
| -20% | -$72.5K | 0.05% | 359 |
|
|
2024
Q3 | $425K | Sell |
10,600
-14,559
| -58% | -$583K | 0.05% | 417 |
|
|
2024
Q2 | $1.2M | Sell |
25,159
-4,777
| -16% | -$228K | 0.15% | 215 |
|
|
2024
Q1 | $1.3M | Buy |
29,936
+20,203
| +208% | +$876K | 0.17% | 163 |
|
|
2023
Q4 | $492K | Buy |
+9,733
| New | +$492K | 0.08% | 300 |
|
|
2023
Q3 | – | Sell |
-5,134
| Closed | -$211K | – | 679 |
|
|
2023
Q2 | $211K | Buy |
+5,134
| New | +$211K | 0.03% | 499 |
|
|
2023
Q1 | – | Sell |
-12,624
| Closed | -$477K | – | 598 |
|
|
2022
Q4 | $477K | Buy |
12,624
+2,376
| +23% | +$89.7K | 0.09% | 338 |
|
|
2022
Q3 | $453K | Sell |
10,248
-1,977
| -16% | -$87.4K | 0.09% | 310 |
|
|
2022
Q2 | $453K | Buy |
12,225
+4,707
| +63% | +$174K | 0.17% | 220 |
|
|
2022
Q1 | $278K | Sell |
7,518
-4,327
| -37% | -$160K | 0.1% | 302 |
|
|
2021
Q4 | $360K | Buy |
+11,845
| New | +$360K | 0.1% | 287 |
|
|
2020
Q3 | – | Sell |
-5,749
| Closed | -$339K | – | 490 |
|
|
2020
Q2 | $339K | Sell |
5,749
-1,419
| -20% | -$83.7K | 0.08% | 367 |
|
|
2020
Q1 | $339K | Buy |
+7,168
| New | +$339K | 1.08% | 27 |
|